Alternative Medications for GERD Treatment

PPI Alternatives to Esomeprazole

The American Gastroenterological Association recommends omeprazole 20 mg once daily as an equivalent alternative to esomeprazole 20 mg once daily according to dose equivalence guidelines 1
Rabeprazole 20 mg once daily is an effective alternative PPI option, as suggested by the American College of Gastroenterology 2
When switching between PPIs, the American Gastroenterological Association recommends following the dose equivalence guidelines: omeprazole 20 mg = lansoprazole 30 mg = esomeprazole 20 mg = pantoprazole 40 mg = rabeprazole 20 mg 1

For severe GERD or erosive esophagitis, the American College of Gastroenterology recommends considering twice-daily dosing if once-daily dosing provides inadequate symptom control 3, 4
PPIs should be taken 30-60 minutes before a meal for optimal efficacy, as recommended by the Clinical Gastroenterology and Hepatology society 4

The American Academy of Pediatrics suggests H2-receptor antagonists (H2RAs) can be considered as second-line therapy when PPIs are not tolerated 5
Equivalent H2RA doses are: famotidine 20 mg twice daily = ranitidine 150 mg twice daily = cimetidine 300 mg three-four times daily = nizatidine 150 mg twice daily, as recommended by the Journal of Hepatology 1
H2RAs are less effective than PPIs for healing erosive esophagitis and providing symptom relief, according to the Gastroenterology society 3
H2RAs have a more rapid onset of action than PPIs, making them useful for on-demand therapy, as suggested by the Gastroenterology society 6

PPIs as a class are more effective than H2RAs for treating GERD symptoms and healing esophagitis, according to the Gastroenterology society 3, 6

Alternative PPIs include omeprazole 20-40 mg, lansoprazole 30 mg, or rabeprazole 20 mg daily, as recommended by the Journal of Hepatology and the American College of Gastroenterology 1, 2
If inadequate response, consider twice-daily PPI dosing, as suggested by the Gastroenterology and Clinical Gastroenterology and Hepatology societies 3, 4
If PPI intolerance, switch to H2RA therapy (famotidine 20 mg twice daily or equivalent), as recommended by the Journal of Hepatology and the American Academy of Pediatrics 1, 5

H2RAs develop tachyphylaxis within 6 weeks, limiting their effectiveness for long-term use, according to the American Academy of Pediatrics 5
Antacids can be used as supplementary therapy for breakthrough symptoms, as suggested by the Gastroenterology society 6
If symptoms persist despite 4-8 weeks of twice-daily PPI therapy, endoscopy should be considered to evaluate for other causes, as recommended by the Annals of Internal Medicine society 2, 7

Avoid metoclopramide as monotherapy or adjunctive therapy for GERD as it's not recommended due to limited efficacy and potential side effects, according to the Gastroenterology society 3
Be aware that cimetidine has been linked to increased risk of liver disease and gynecomastia, which may potentially affect other H2RAs as well, as suggested by the American Academy of Pediatrics 5
Recognize that PPIs may have side effects including headache, diarrhea, constipation, and abdominal pain; switching to another PPI can often resolve these issues, according to the Gastroenterology society 6